2026-04-27T10:14:38-05:00 2025-06-30 334358135 SAX ADVISORS LLC 1040 AVENUE OF THE AMERICAS 16TH FLOOR NEW YORK NY 10018 990 2024-07-01 521704978 CUREPSP INC CURE 6467251453 325 HUDSON STREET 4TH FLOOR NEW YORK NY 100131045 KRISTOPHE DIAZ EXECUTIVE DIRECTOR 6467251453 2026-04-27 1 0 MIKE SCHALL P02024184 2122682804 2026-03-27 2024 2025-03-06 01:10:19Z KRISTOPHE DIAZ 325 HUDSON STREET 4TH FLOOR NEW YORK NY 100131045 8077951 0 X WWW.CUREPSP.ORG X 1990 MD TO RAISE AWARENESS, BUILD COMMUNITY, IMPROVE CARE AND FIND A CURE FOR PSP, CBD AND MSA. 14 14 17 350 0 0 5179385 7506914 0 0 -82146 370642 30447 25718 5127686 7903274 1171461 1740086 0 0 1688770 2059203 0 0 518814 1985687 2066564 4845918 5865853 281768 2037421 8687169 11029404 1133772 1139409 7553397 9889995 X TO RAISE AWARENESS, BUILD COMMUNITY, IMPROVE CARE AND FIND A CURE FOR PSP, CBD AND MSA. 0 0 2252697 1170733 3218 CUREPSP SUPPORTS SCIENTIFIC RESEARCH AIMED AT DEVELOPING NEW TREATMENTS AND ULTIMATELY A CURE FOR PROGRESSIVE SUPRANUCLEAR PALSY (PSP) AND CORTICOBASAL DEGENERATION (CBD), BOTH PRIMARY TAUOPATHIES. THE ORGANIZATION FUNDS AND FACILITATES RESEARCH PROJECTS THAT ADVANCE UNDERSTANDING OF THESE DISEASES WHILE ALSO CONTRIBUTING TO BROADER SCIENTIFIC KNOWLEDGE RELEVANT TO OTHER NEURODEGENERATIVE CONDITIONS, INCLUDING ALZHEIMER'S DISEASE, PICK'S DISEASE, ARGYROPHILIC GRAIN DISEASE, CHRONIC TRAUMATIC ENCEPHALOPATHY, AND CERTAIN FORMS OF FAMILIAL FRONTOTEMPORAL DEMENTIA.CONTINUED ON SCHEDULE OCUREPSP'S FUNDING AND PARTNERSHIPS ARE STRATEGICALLY FOCUSED ON ADVANCING RESEARCH IN SEVERAL KEY AREAS: (A) UNDERSTANDING THE CAUSES AND RISK FACTORS OF NEURODEGENERATION, (B) DISCOVERING AND VALIDATING ACTIONABLE BIOMARKERS AND CLINICAL TESTS TO ENHANCE DIAGNOSIS AND INCREASE THE LIKELIHOOD OF MORE EFFECTIVE CLINICAL TRIALS, (C) IDENTIFYING GENETIC VARIANTS LINKED TO THESE DISEASES, (D) DEVELOPING THERAPIES THAT COULD PREVENT, HALT, OR REVERSE THE BRAIN DAMAGE CAUSED BY THE PATHOLOGICAL ACCUMULATION OF PROTEINS, (E) ASSISTING PHARMACEUTICAL, BIOTECH, AND DIAGNOSTIC COMPANIES, AS WELL AS RESEARCH INSTITUTIONS, IN RECRUITING AND PROMOTING PARTICIPATION IN CLINICAL TRIALS, AND (F) DEVELOPING STRATEGIC ASSETS THAT DIRECTLY BENEFIT INDUSTRY PARTNERS, SUCH AS THE COMPREHENSIVE PATIENT JOURNEY STUDY, WHICH PROVIDES DETAILED INSIGHTS INTO THE REAL-WORLD EXPERIENCES OF PATIENTS TO INFORM AND OPTIMIZE CLINICAL TRIAL DESIGN. ADDITIONALLY, CUREPSP COLLABORATES WITH LEADING INSTITUTIONS LIKE THE MAYO CLINIC'S BRAIN BANK IN JACKSONVILLE, FLORIDA, TO PROVIDE ESSENTIAL BRAIN TISSUE SAMPLES TO RESEARCHERS WORLDWIDE, EXPANDING ACCESS TO THESE CRUCIAL BIOLOGICAL RESOURCES. CUREPSP'S PARTNERSHIPS ARE DESIGNED TO FAST-TRACK SHARED OBJECTIVES. IN THIS EFFORT, CUREPSP WORKS CLOSELY WITH AND CO-INVESTS IN PROGRAMS AND RESEARCH ALONGSIDE PROMINENT NONPROFIT ORGANIZATIONS AND FOUNDATIONS, SUCH AS THE ALZHEIMER'S ASSOCIATION, THE MICHAEL J. FOX FOUNDATION, THE PARKINSON'S FOUNDATION, AND THE RAINWATER CHARITABLE FOUNDATION, AS WELL AS PATIENT-LED ORGANIZATIONS LIKE MISSION MSA IN THE UNITED STATES AND THE PSP ASSOCIATION IN THE UNITED KINGDOM. 1101271 30000 THE PREVALENCE OF PROGRESSIVE SUPRANUCLEAR PALSY (PSP) IS COMPARABLE TO THAT OF ALS (AMYOTROPHIC LATERAL SCLEROSIS), YET PSP, ALONG WITH CORTICOBASAL DEGENERATION (CBD) AND MULTIPLE SYSTEM ATROPHY (MSA), REMAINS SIGNIFICANTLY UNDERRECOGNIZED COMPARED TO ALS. CUREPSP IS DEDICATED TO RAISING AWARENESS FOR THESE CONDITIONS AND SUPPORTING THE PATIENTS, FAMILIES, AND CAREGIVERS AFFECTED BY THEM, EMPOWERING THEM TO ADVOCATE EFFECTIVELY FOR THEIR NEEDS. THE ORGANIZATION IS COMMITTED TO ENHANCING QUALITY OF LIFE AND PATIENT OUTCOMES BY BUILDING A RESILIENT AND SUPPORTIVE COMMUNITY THAT GROW AWARENESS NATIONALLY AND GLOBALLY. CONTINUED ON SCHEDULE OCUREPSP PURSUES THESE GOALS THROUGH VOLUNTEER DEVELOPMENT PROGRAMS, PROFESSIONAL EDUCATION, AND THE DISTRIBUTION OF EDUCATIONAL RESOURCES BOTH ONLINE AND IN PRINT FOR THE PUBLIC AND HEALTHCARE PROFESSIONALS. ADDITIONALLY, IT ACTIVELY SHARES VITAL INFORMATION THROUGH SOCIAL MEDIA AND ONLINE NEWSLETTERS. CUREPSP ENGAGES IN ADVOCACY TO ADVANCE PUBLIC POLICIES THAT IMPROVE CARE, SUPPORT RESEARCH, AND INCREASE AWARENESS. THE ORGANIZATION MOBILIZES PATIENTS, CARE PARTNERS, AND VOLUNTEERS TO PARTICIPATE IN LEGISLATIVE OUTREACH, EDUCATES POLICYMAKERS ABOUT THE NEEDS OF THE COMMUNITY, AND COLLABORATES WITH NATIONAL ADVOCACY COALITIONS TO PROMOTE POLICIES THAT EXPAND ACCESS TO CARE, SUPPORT FAMILY CARE PARTNERS, IMPROVE DIAGNOSTICS, AND INCREASE FEDERAL INVESTMENT IN RESEARCH. THROUGH THESE EFFORTS, CUREPSP HAS HELPED ADVANCE FEDERAL AND STATE POLICY INITIATIVES RELATED TO TELEHEALTH ACCESS, COORDINATED NATIONAL STRATEGIES FOR PARKINSONIAN DISEASES, AND INCREASED RECOGNITION OF THESE CONDITIONS WITHIN FEDERAL RESEARCH PRIORITIES. 1398788 539353 CUREPSP PUBLISHES A LIBRARY OF PRINTED AND ONLINE EDUCATIONAL MATERIALS FOR FAMILIES, PATIENTS, PHYSICIANS, AND OTHER HEALTHCARE PROFESSIONALS. THESE MATERIALS ARE DEVELOPED IN COLLABORATION WITH CUREPSP CENTERS OF CARE, A NETWORK OF HOSPITALS AND BEST-IN-CLASS ACADEMIC CENTERS SPECIALIZING IN TREATING PATIENTS WITH PSP, CBD, AND MSA. CUREPSP SPONSORS EDUCATIONAL CONFERENCES IN COLLABORATION WITH LEADING INSTITUTIONS TO INCREASE KNOWLEDGE AND SUPPORT PEOPLE LIVING WITH THESE FATAL DISEASES. THE OBJECTIVE IS TO PROMOTE EDUCATION, EARLIER AND MORE ACCURATE DIAGNOSIS AND BETTER PATIENT CARE. SEVERAL DOZEN VOLUNTEER EVENTS ANNUALLY, SUPPORTED BY CUREPSP, FURTHER EDUCATE, AND EMPOWER OUR COMMUNITY TO PREPARE FOR THEIR CARE NEEDS. (CONTINUE ON SCHEDULE O)CUREPSP UTILIZES SOCIAL MEDIA, ONLINE PLATFORMS, AND EDUCATIONAL PROGRAMMING TO COMMUNICATE WITH AND SUPPORT PATIENTS, CARE PARTNERS, AND HEALTHCARE PROFESSIONALS. THE ORGANIZATION MAINTAINS AN ONLINE PATIENT AND CAREGIVER FORUM, PRODUCES NATIONAL WEBINARS AND EDUCATIONAL PRESENTATIONS FROM CLINICIANS AND RESEARCHERS, AND HOSTS "ASK THE EXPERTS" INTERACTIVE SESSIONS. CUREPSP ALSO ORGANIZES ONLINE SUPPORT GROUPS, ANNUAL WELLNESS WORKSHOPS, AND AN IN-PERSON COMMUNITY GATHERING TO HELP INDIVIDUALS MANAGE DISEASE BURDEN AND THE CHALLENGES OF CAREGIVING. THROUGH THE CUREPSP QUALITY OF LIFE RESPITE GRANT PROGRAM, SUPPORTED BY THE CHERIE LEVIEN QUALITY OF LIFE FUND AND OTHER DONORS, THE ORGANIZATION PROVIDES FINANCIAL ASSISTANCE TO HELP FAMILIES ACCESS PROFESSIONAL IN-HOME CARE. CUREPSP SUPPORTS MORE THAN 50 VIRTUAL AND IN-PERSON SUPPORT GROUPS AND LEVERAGES A GLOBAL NETWORK OF MORE THAN 350 VOLUNTEERS TO PROVIDE ONLINE, TELEPHONE, AND FACE-TO-FACE SUPPORT.CUREPSP ESTABLISHED THE CUREPSP CENTERS OF CARE NETWORK IN 2017 TO IMPROVE ACCESS TO HIGH-QUALITY, SPECIALIZED CLINICAL CARE. MEDICAL CENTERS ARE DESIGNATED BASED ON CRITERIA INCLUDING EXPERTISE IN DIAGNOSIS AND MANAGEMENT, AVAILABILITY OF MULTIDISCIPLINARY CARE AND SUPPORT SERVICES, AND PARTICIPATION IN CLINICAL RESEARCH. THROUGH THIS NETWORK, CUREPSP COLLABORATES WITH LEADING MEDICAL CENTERS TO PROMOTE EARLIER DIAGNOSIS, ADVANCE BEST PRACTICES IN CARE, EXPAND ACCESS TO SPECIALIZED SERVICES, AND SUPPORT CLINICAL RESEARCH. THE NETWORK NOW INCLUDES CENTERS IN THE UNITED STATES AND CANADA, WITH ADDITIONAL CENTERS PLANNED IN EUROPE. 4752756 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 37 0 1 17 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 14 14 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 1 0 0 AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X X KRISTOPHE DIAZ 6467251453 325 HUDSON STREET 4TH FLOOR NEW YORK NY 100131045 JACK PHILLIPS CHAIR 25.00 X X 0 0 0 AMY BRANCH VICE CHAIR 8.00 X X 0 0 0 JUSTIN SHEA TREASURER 2.00 X X 0 0 0 LAWRENCE LEVIEN SECRETARY 1.00 X X 0 0 0 LAWRENCE GOLBE CHAIR - SCIENTIFIC ADVISOR 2.00 X X 0 0 0 WILLIAM MCFARLAND DIRECTOR 3.00 X 0 0 0 JAMES MCCLELLAN DIRECTOR 0.50 X 0 0 0 ILEEN MCFARLAND DIRECTOR 35.00 X 0 0 0 LOUIS FOXWELL DIRECTOR 3.00 X 0 0 0 ALEXANDER PANTELYAT DIRECTOR 3.00 X 0 0 0 PAUL FREEMAN DIRECTOR 3.00 X 0 0 0 MANA BHATT SANGHVI DIRECTOR 2.00 X 0 0 0 NADINE TATTON DIRECTOR 0.50 X 0 0 0 MARIA SCHMIDT DIRECTOR 2.00 X 0 0 0 KRISTOPHE J DIAZ EXE DIR AND CHIEF SCIENCE OFFICER 40.00 X 266514 0 23982 RICHARD T SPAIN IV DIRECTOR, DEVELOPMENT 40.00 X 161643 0 22585 JENNIFER L BRUMMET ASSOC. DIR. CLINICAL AFFAIRS AND ADVOCACY 40.00 X 149533 0 22420 JESSICA SHURER DIR. CLINICAL AFFAIRS AND ADVOCACY 40.00 X 113088 0 21205 690778 0 90192 4 0 1 0 REGINA PRINTING 260 WAGNER STREET MIDDLESEX NJ 08846 PRINTING SERVICES 407797 DEVELOPING NOW INC 134 N 4TH STREET FLOOR 2 BROOKLYN NY 11249 WEBSITE DEVELOPEMENT SERVICES 114000 ARABELLA ADVISORS LLC 1828 L ST NORTHWEST STE 300 WASHINGTON DC 20036 ACCOUNTING SERVICES 107487 3 615392 6891522 62614 7506914 369113 369113 110000 108471 1529 1529 1529 64463 615392 64463 0 4961 1743 3218 3218 OTHER REVENUE 900099 22500 22500 22500 7903274 3218 0 393142 1361000 1361000 255643 255643 123443 123443 310127 248101 31013 31013 1385868 1079462 128010 178396 27806 21638 2555 3613 220885 183780 7595 29510 114517 89626 10711 14180 61277 61277 135576 135576 16874 16874 159526 128631 21895 9000 418829 318356 2011 98462 6524 5693 332 499 210206 142180 11482 56544 65209 50900 3995 10314 242177 179915 27131 35131 124825 98640 6796 19389 110254 86289 10313 13652 8789 8789 RESEARCH 291903 291903 OTHER EXPENSES 143335 32564 105218 5553 POSTAGE AND SHIPPING 62309 47992 759 13558 PHOTOGRAPHY AND VIDEOGR 7000 7000 1951 1951 5865853 4752756 594283 518814 326774 1509956 949402 1255437 314706 19105 4623 5533 167944 191712 318111 227363 530039 378601 204692 151438 6395653 7631258 5264 37602 8687169 11029404 197082 555796 688177 327262 248513 223513 0 32838 1133772 1139409 X 5724836 7258098 1828561 2631897 7553397 9889995 8687169 11029404 2037421 299177 0 X 0 1 X 1 0 X 6290908 3585545 3237361 5179385 7506914 25800113 7971 5729 4961 18661 6290908 3585545 3245332 5185114 7511875 25818774 82413 122202 89000 25000 2632 321247 0 82413 122202 89000 25000 2632 321247 25497527 18990 237008 189592 173534 369113 988237 18990 237008 189592 173534 369113 988237 23693 3984 11183 27583 22500 88943 6333591 3826537 3446107 5386231 7903488 26895954 0.94800 0.94950 0.03670 0.03090 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 363961 35025 29672 369314 357599 41672 35310 363961 351053 32546 26000 357599 397078 -43025 3000 351053 316620 80458 397078 1.00000 0 0 40743 37835 2908 489296 340766 148530 151438 OPERATING LEASE LIABILITIES 32838 32838 X 8202451 299177 299177 7903274 0 7903274 5865853 0 5865853 0 5865853 PART X, LINE 2: THE ORGANIZATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE ANY UNCERTAIN TAX POSITIONS. TAX FILING FOR THE PERIOD ENDING JUNE 30, 2022 AND LATER ARE SUBJECT TO EXAMINATION BY APPLICABLE TAXING AUTHORITIES. 1 CANADA 0 0 GRANTMAKING FY25 CENTER OF CARE AWARD GRANT 20000 ARGENTINA 0 0 GRANTMAKING STUDENT FELLOWSHIP GRANT - CURE PILLAR OF OUR MISSION 5000 JAPAN 0 0 GRANTMAKING FUNDING RESEARCH - CURE PILLAR OF OUR MISSION 98443 0 0 0 0 0 0 123443 0 123443 JAPAN FUNDING RESEARCH - CURE PILLAR OF OUR MISSION 98443 0 CANADA FY25 CENTER OF CARE AWARD GRANT 20000 0 0 0 0 0 0 0 PART I, LINE 2: GRANT RECIPIENTS MUST ADHERE TO SPECIFIC REPORTING GUIDELINES THROUGHOUT THE DURATION OF THEIR FUNDING. AT THE MIDPOINT OF THE GRANT PERIOD, INVESTIGATORS MUST SUBMIT BOTH A FINANCIAL REPORT AND A SCIENTIFIC PROGRESS REPORT. THESE REPORTS PROVIDE A DETAILED ACCOUNT OF THE FINANCIAL EXPENDITURES RELATED AND SUMMARIZE THE SCIENTIFIC ADVANCES ACHIEVED TO DATE AND ACCORDING TO THE PROJECT PLAN. AT THE CONCLUSION OF THE GRANT PERIOD, A FINAL SET OF FINANCIAL AND SCIENTIFIC PROGRESS REPORTS MUST BE SUBMITTED. THESE DOCUMENTS ARE CRUCIAL FOR EVALUATING THE OUTCOMES AND FISCAL MANAGEMENT OF THE PROJECT. THE REPORTS ARE REVIEWED BY THE ASSOCIATE DIRECTOR OF SCIENTIFIC AFFAIRS AND THE CHIEF SCIENCE OFFICER, AND SUBSEQUENT FUNDING DISBURSEMENTS ARE CONTINGENT UPON APPROVAL. FAILURE TO SUBMIT SATISFACTORY REPORTS MAY RESULT IN THE WITHHOLDING OF PAYMENTS. ANNUAL CUREPSP 379610 351803 27807 441 27367 MARATHON 68389 56026 12363 12363 231856 207563 24293 24292 679855 615392 64463 441 64022 64463 0 1 NORTH TEXAS COMMUNITY FOUNDATION 777 MAIN STREET STE 2850 FORTH WORTH TX 76102 752267767 501 (C) (3) 200000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION REGENERATIVE RESEARCH FOUNDATION 150 NEW SCOTLAND AVENUE ALBANY NY 12208 203654626 501 (C) (3) 150000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION ALZHEIMERS ASSOCIATION 225 NORTH MICHIGAN AVENUE 17TH FLOOR CHICAGO IL 60601 133039601 501 (C) (3) 125000 0 SPECIAL INITIATIVE GRANT: REIMB. FOR GLOBAL TAU MEETING, LONDON, APRIL 24-25, 2025 BAYLOR COLLEGE OF MEDICINE - GRANTS ONE BAYLOR PLAZA MS BCM 206 HOUSTON TX 77030 741613878 501 (C) (3) 100000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION MAYO CLINIC JACKSONVILLE 4500 SAN PABLO ROAD SOUTH JACKSONVILLE FL 32224 593337028 501 (C) (3) 100000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION UNIVERSITY OF MASSACHUSETTS 50 WASHINGTON STREET SUITE 3000 WESTBOROUGH MA 01581 043167352 501 (C) (3) 100000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION UNIVERSITY OF NEBRASKA MEDICAL CENTER 985045 NEBRASKA MEDICAL CENTER OMAHA NE 68198 470049123 501 (C) (3) 100000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION WASHINGTON UNIVERSITY 4320 BROOKLYN AVENUE NORTHEAST SUITE 5 SEATTLE WA 98105 916001537 501 (C) (3) 100000 0 FUNDING RESEARCH - CURE PILLAR OF OUR MISSION STANFORD OFFICE OF RESEARCH ADMINISTRATION PO BOX 884253 LOS ANGELES CA 90088 941156365 501 (C) (3) 50000 0 FY25 CENTER OF CARE AWARD GRANT MICHIGAN STATE UNIVERSITY 426 AUDITORIUM ROAD ROOM 360 EAST LANSING MI 48824 386005984 501 (C) (3) 45000 0 FY25 CENTER OF CARE AWARD GRANT UNIVERSITY RESEARCH ADMINISTRATION - UNIV OF CHICAGO 6054 SOUTH DREXEL AVENUE SUITE 300 CHICAGO IL 60637 362177139 501 (C) (3) 40000 0 FY25 CENTER OF CARE AWARD GRANT THE MICHAEL J FOX FOUNDATION 111 WEST 33RD STREET 10TH FLOOR NEW YORK NY 10001 134141945 501 (C) (3) 30000 0 SPECIAL INITIATIVE GRANT: SPONSORSHIP OF THE ECONOMIC BURDEN REPORT FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH 11400 ROCKVILLE PIKE SUITE 600 NORTH BETHESDA MD 20852 521986675 501 (C) (3) 25000 0 SPECIAL INITIATIVE GRANT: PARTNERSHIP WITH FNIH - AMP PDRD INITIATIVE UNIVERSITY OF TEXAS AT SAN ANTONIO ONE UTSA CIRCLE GIFT SERVICES SAN ANTONIO TX 78249 741717115 501 (C) (3) 10000 0 STUDENT FELLOWSHIP GRANTS - CURE PILLAR OF OUR MISSION FASEB 6120 EXECUTIVE BLVD SUITE 230 ROCKVILLE MD 20852 520700497 501 (C) (3) 6000 0 SPONSORSHIP AT FASEB MEETING SJO RESEARCH & CONSULTING 205 COUNTRY LANE PHOENIXVILLE PA 19460 451290156 501 (C) (3) 54474 0 RESEARCH GRANT 15 1 BRAIN TISSUE GRANTS 38 36192 RESPITE CARE FUND 92 219451 PART I, LINE 2: INVESTIGATORS ARE REQUIRED TO PROVIDE TWO PROGRESS REPORTS DURING THE TERM OF THE GRANT. THE PROGRESS REPORT IS SENT FOR REVIEW AND APPROVAL TO THE VICE PRESIDENT OF SCIENTIFIC AFFAIRS AND PAYMENT MAY BE RELEASED ONLY AFTER APPROVAL HAS BEEN GIVEN. IF PROGRESS REPORTS ARE NOT DETERMINED TO BE SATISFACTORY, PAYMENT MAY BE WITHHELD UNTIL THE INVESTIGATOR CAN PROVIDE A SATISFACTORY REPORT. X 0 0 0 0 0 0 0 0 0 KRISTOPHE J DIAZ EXE DIR AND CHIEF SCIENCE OFFICER 236514 0 30000 0 0 0 5197 0 18785 0 290496 0 0 0 RICHARD T SPAIN IV DIRECTOR, DEVELOPMENT 151643 0 10000 0 0 0 4549 0 18036 0 184228 0 0 0 JENNIFER L BRUMMET ASSOC. DIR. CLINICAL AFFAIRS AND ADV 149533 0 0 0 0 0 4384 0 18036 0 171953 0 0 0 X 9 62614 FMV 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 WILLIAM R. MCFARLAND AND ILEEN J MCFARLAND ARE HUSBAND AND WIFE. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS PROVIDED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL. THE FORM IS THEN PROVIDED TO THE FULL BOARD OF DIRECTORS FOR A PERIOD TO MAKE COMMENTS BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A BOARD APPROVED CONFLICTS OF INTEREST POLICY. EACH BOARD MEMBER MUST FILL OUT AN ANNUAL DECLARATION STATING THEY HAD NO CONFLICTS OR IDENTIFYING THE NATURE OF THEIR INTERESTED PARTY TRANSACTIONS. FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS DISCUSSED PERFORMANCE AND USES SALARY DATA TO DETERMINE. PERIODICALLY THE BOARD ALSO OBTAINS AN INDEPENDENT COMPENSATION STUDY TO DETERMINE SALARY LEVELS. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS ARE MADE AVAILABLE UPON REQUEST.